Synexus, the largest multinational company in the world that is solely dedicated to successfully recruiting and running clinical studies are now recruiting patients to take part in a study that will assess a brand new treatment aimed at bringing relief to those who suffer from an overactive bladder. The clinical research centres involved in the study are located in Merseyside, Thames Valley and Lancashire.
1 in 6 UK adults suffer from overactive bladder syndrome, and if you are one of them you will know exactly how overwhelming the symptoms are. Typically, they are sudden and uncontrollable urges to go to the loo, frequent visits through day and even waking in the night to go. It is debilitating, inconvenient and disruptive, but the good news is that an overactive bladder is very common, and can potentially be treated.
The new study which Synexus is running currently assesses a new treatment than can help to give suffers real relief from their overactive bladder problem.
o Have been diagnosed with overactive bladder or are displaying symptoms
o Have been suffering with overactive bladder for at least 3 months
Synexus is currently recruiting patients for this study at its Dedicated Clinical Research Centres in Lancashire, Merseyside and Thames Valley.
Those who would like to find out more or are interested in participating in this study should contact:
o Lancashire Clinical Research Centre – 01772 344620 (quote reference 2363)
o Merseyside Clinical Research Centre – 0151 5509951 (quote reference 2364)
o Thames Valley Clinical Research Centre – 0118 3789923 (quote reference 2365)
And quote your name, address, phone number and reference code.
There is no obligation for people to participate and if they do decide to take part, their GP will be kept fully informed of their involvement.
Synexus has many years experience in conducting a wide range of clinical studies. The purpose of a clinical research study is to answer important questions about a new medicine, for example: does it improve a person’s health and which dose of the medicine works best?
Each year, thousands of patients take part in clinical studies at Synexus’ Dedicated Clinical Research Centres. There are many different studies running at each of the Centres throughout the year including potential treatments for conditions such as osteoporosis, smoking cessation, high-cholesterol, insomnia, vaccines, asthma and childhood eczema.
Not all studies are paid, but some do reimburse the patients for their time and all reimburse patients for out of pocket travelling expenses. Participating in a Synexus clinical study means patients receive increased medical attention and may benefit from medications that aren’t yet available to other sufferers of their condition, while making a positive contribution to the health of future generations.
For more information about Synexus and the other studies that it is currently conducting visit www.improvinghealth.com